| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000046560 |
| Receipt No. | R000052932 |
| Scientific Title | The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy |
| Date of disclosure of the study information | 2022/01/06 |
| Last modified on | 2022/01/06 (Ver. 1) |
| Basic information | ||
| Public title | The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy | |
| Acronym | The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy | |
| Scientific Title | The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy | |
| Scientific Title:Acronym | The effect of ultrasound-guided floor muscle training on urinary incontinence in patients after robot-assisted radical prostatectomy | |
| Region |
|
|
| Condition | ||
| Condition | Prostate cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We will clarify whether the guidance of pelvic floor muscle exercises under abdominal ultrasonography, which could monitor the movement of pelvic floor muscles, contributes to the improvement of urinary incontinence rate in comparison with the paper-based pelvic floor muscle training guidance group. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Urinary incontinence rate during hospitalization and at 1,3,6 months after operation. |
| Key secondary outcomes | (1)Mental burden of performing ultrasonic examination(2)Do you feel that pelvic floor muscle exercises contribute to the improvement of urinary incontinence? (questionnaire) (3)Whether they feel they are getting effective training. (questionnaire)(4)Whether pelvic floor muscle training is still being provided after discharge from the hospital (questionnaire)(5)How do you feel about the degree of urinary incontinence (questionnaire)?(6)Urinary incontinence rate in the nerve-sparing group(7)Urinary incontinence rate in the non-nerve-preserving group. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subjects were patients undergoing robot assisted radical prostatectomy(RARP). Fifty patients received pelvic floor muscle exercise instruction on ultrasound in addition to paper instruction. The survey will include measurements of daily urine volume and frequency, in-diaper urinary incontinence volume, and urinary incontinence rate, as well as a questionnaire on the implementation and effectiveness of the training. Allocation method: After obtaining consent to participate in the study, a distinction was made between groups of patients who underwent nerve-sparing and non-sparing techniques. Then the instructional method was assigned in each. Among the nerve-sparing/non-nerve sparing techniques, the age group was divided by decade. The odd numbers in the built-in order are divided into the instruction group under abdominal ultrasound, and the even numbers are divided into the instruction group on paper.
Instruct pelvic floor muscle training using pamphlets with/without abdominal ultrasonography before and after surgery. From the day after removal of the urethral catheter, daily urine volume and frequency, as well as the amount of urinary incontinence in the diaper, were measured. The urinary incontinence rate is calculated from the daily urine volume and the amount of urinary incontinence in the diaper. In addition, a questionnaire survey will be conducted in the period leading up to discharge from the hospital. At the outpatient visit 1 month, 3 months, and 6 months after discharge, the research members collect information on the daily urine volume and frequency, and the amount of urinary incontinence in the diaper from the urination diary. The urinary incontinence rate is calculated. |
|
| Interventions/Control_2 | Fifty patients who underwent RARP, will be trained with only paper-based pelvic floor muscle exercise instruction.
In this group, as in the therapeutic intervention group, the groups were divided by the presence or absence of nerve preservation and stratified by age. The content of the survey is the same as in the treatment intervention group. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Patients who meet all of the following criteria are included.
(1) Robot-assisted radical prostatectomy patient. (2) Age: At the time of obtaining consent, the age is 50 years or older. (3) Gender: Male. (4)Inpatient / Outpatient: Inpatient and outpatient. (5) Patients who have fully understood the sufficient explanation of this study and have given written consent of their own free will. |
|||
| Key exclusion criteria | (1) Patients with cognitive decline who are judged by the principal investigator. And sub-investigators to be unsuitable as subjects, and patients who cannot understand the instruction and cannot perform pelvic floor muscle training on their own will.
(2) In addition, patients who are judged by the principal investigator to be inappropriate as research subjects. (3) Patients who continue to take concomitantly prohibited or excluded drugs after surgery. Banned drugs: Drugs that may reduce urinary incontinence. 1)Stress Urinary Incontinence Treatment. 2)Overactive bladder remedies. Concomitant exclusions: Drugs that may reduce urinary incontinence. 1)Other anticholinergic agents. |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Fukui Hospital | ||||||
| Division name | Nursing Department | ||||||
| Zip code | 910-1193 | ||||||
| Address | 23-3 Matsuoka Shimoaizuki,Eiheiji-cho,Yoshida-gun,Fukui 910-1193 Japan | ||||||
| TEL | 0776-61-3111 | ||||||
| isseihri@u-fukui.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Fukui Hospital | ||||||
| Division name | Nursing Department | ||||||
| Zip code | 910-1193 | ||||||
| Address | 23-3 Matsuoka Shimoaizuki,Eiheiji-cho,Yoshida-gun,Fukui 910-1193 Japan | ||||||
| TEL | 0776-61-3111 | ||||||
| Homepage URL | |||||||
| isseihri@u-fukui.ac.jp | |||||||
| Sponsor | |
| Institute | University of Fukui Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Medical Research Support Center/University of Fukui Hospital |
| Address | 23-3 Matsuoka Shimoaizuki,Eiheiji-cho,Yoshida-gun,Fukui 910-1193 Japan |
| Tel | 0776-61-8529 |
| chiken@ml.u-fukui.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052932 |